ReWalk Robotics (NASDAQ:LFWD) Posts Earnings Results, Misses Expectations By $1.53 EPS

ReWalk Robotics (NASDAQ:LFWD) posted its quarterly earnings data on Friday. The company reported ($1.73) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($1.53), Zacks reports. ReWalk Robotics had a negative net margin of 77.21% and a negative return on equity of 43.02%. ReWalk Robotics updated its FY 2025 guidance to EPS.

ReWalk Robotics Stock Down 9.5 %

NASDAQ:LFWD traded down $0.15 during trading hours on Friday, reaching $1.43. 89,958 shares of the company’s stock were exchanged, compared to its average volume of 226,047. The company has a market capitalization of $15.20 million, a P/E ratio of -0.58 and a beta of 2.05. ReWalk Robotics has a 12 month low of $1.25 and a 12 month high of $6.00. The business’s 50-day simple moving average is $1.77 and its two-hundred day simple moving average is $2.28.

Analyst Ratings Changes

LFWD has been the subject of a number of research reports. HC Wainwright reaffirmed a “buy” rating and set a $13.00 price target on shares of ReWalk Robotics in a research note on Thursday, February 20th. Laidlaw began coverage on ReWalk Robotics in a report on Monday, February 10th. They issued a “buy” rating and a $10.00 price objective for the company. Finally, Lake Street Capital lowered their target price on ReWalk Robotics from $6.00 to $4.50 and set a “buy” rating on the stock in a report on Thursday, February 20th.

Insider Buying and Selling at ReWalk Robotics

In related news, major shareholder Global Fund Lp Lind II sold 381,676 shares of the stock in a transaction on Monday, January 6th. The stock was sold at an average price of $3.36, for a total value of $1,282,431.36. Following the completion of the transaction, the insider now owns 1,049,430 shares in the company, valued at $3,526,084.80. This trade represents a 26.67 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 2.50% of the stock is owned by corporate insiders.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.